| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 12 | 2023 | 57 | 6.820 |
Why?
|
| Stress Disorders, Post-Traumatic | 13 | 2023 | 218 | 3.330 |
Why?
|
| Mental Disorders | 12 | 2021 | 134 | 3.270 |
Why?
|
| Veterans | 9 | 2022 | 86 | 2.720 |
Why?
|
| Analgesics, Opioid | 5 | 2022 | 209 | 2.440 |
Why?
|
| Adolescent | 44 | 2024 | 1855 | 2.370 |
Why?
|
| Substance-Related Disorders | 8 | 2024 | 88 | 2.210 |
Why?
|
| Homeless Youth | 6 | 2022 | 14 | 2.160 |
Why?
|
| Humans | 89 | 2024 | 22592 | 2.160 |
Why?
|
| Alcoholism | 7 | 2022 | 62 | 2.060 |
Why?
|
| Electronic Health Records | 8 | 2021 | 64 | 1.910 |
Why?
|
| Mental Health Services | 6 | 2021 | 35 | 1.870 |
Why?
|
| Psychiatry | 3 | 2021 | 12 | 1.740 |
Why?
|
| Prescription Drug Misuse | 3 | 2019 | 6 | 1.720 |
Why?
|
| Buprenorphine | 2 | 2023 | 3 | 1.540 |
Why?
|
| Machine Learning | 7 | 2021 | 59 | 1.490 |
Why?
|
| Primary Health Care | 4 | 2020 | 72 | 1.480 |
Why?
|
| Depressive Disorder | 4 | 2019 | 163 | 1.470 |
Why?
|
| Antipsychotic Agents | 5 | 2021 | 50 | 1.440 |
Why?
|
| United States | 19 | 2024 | 1741 | 1.350 |
Why?
|
| Research Design | 4 | 2022 | 152 | 1.350 |
Why?
|
| Young Adult | 20 | 2021 | 1607 | 1.350 |
Why?
|
| Prisoners | 6 | 2013 | 10 | 1.350 |
Why?
|
| Inpatients | 4 | 2020 | 114 | 1.340 |
Why?
|
| Female | 51 | 2024 | 12734 | 1.330 |
Why?
|
| Juvenile Delinquency | 8 | 2011 | 15 | 1.310 |
Why?
|
| Male | 48 | 2024 | 12260 | 1.240 |
Why?
|
| Gender Identity | 2 | 2021 | 19 | 1.190 |
Why?
|
| Child | 18 | 2022 | 1148 | 1.190 |
Why?
|
| Aggression | 5 | 2018 | 23 | 1.180 |
Why?
|
| Adult | 28 | 2022 | 6826 | 1.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 31 | 1.120 |
Why?
|
| Referral and Consultation | 4 | 2022 | 78 | 1.090 |
Why?
|
| Child Psychiatry | 3 | 2018 | 5 | 1.020 |
Why?
|
| Nurse Practitioners | 2 | 2018 | 33 | 1.020 |
Why?
|
| Natural Language Processing | 6 | 2021 | 10 | 0.990 |
Why?
|
| Transgender Persons | 3 | 2021 | 20 | 0.970 |
Why?
|
| Behavior, Addictive | 2 | 2023 | 8 | 0.970 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 83 | 0.930 |
Why?
|
| Patient Discharge | 3 | 2021 | 146 | 0.920 |
Why?
|
| Foster Home Care | 2 | 2017 | 4 | 0.910 |
Why?
|
| Telemedicine | 2 | 2024 | 84 | 0.880 |
Why?
|
| Delphi Technique | 2 | 2022 | 23 | 0.880 |
Why?
|
| Consensus | 2 | 2022 | 81 | 0.860 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 16 | 0.830 |
Why?
|
| Mentoring | 1 | 2023 | 24 | 0.770 |
Why?
|
| Length of Stay | 2 | 2020 | 293 | 0.720 |
Why?
|
| Cannabis | 1 | 2021 | 9 | 0.720 |
Why?
|
| Sexual and Gender Minorities | 2 | 2019 | 22 | 0.720 |
Why?
|
| National Institute on Drug Abuse (U.S.) | 1 | 2021 | 1 | 0.700 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2021 | 16 | 0.690 |
Why?
|
| Risk-Taking | 3 | 2019 | 27 | 0.690 |
Why?
|
| Crime Victims | 2 | 2024 | 23 | 0.650 |
Why?
|
| Cultural Diversity | 3 | 2004 | 20 | 0.650 |
Why?
|
| Middle Aged | 17 | 2021 | 7800 | 0.630 |
Why?
|
| Adolescent Psychiatry | 2 | 2018 | 2 | 0.630 |
Why?
|
| Depression | 3 | 2019 | 368 | 0.620 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 249 | 0.620 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 68 | 0.620 |
Why?
|
| Bullying | 1 | 2019 | 2 | 0.620 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2019 | 3 | 0.620 |
Why?
|
| Patient Health Questionnaire | 1 | 2019 | 11 | 0.600 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 18 | 0.600 |
Why?
|
| Psychotropic Drugs | 2 | 2017 | 25 | 0.590 |
Why?
|
| Opiate Substitution Treatment | 3 | 2023 | 3 | 0.580 |
Why?
|
| Community Health Centers | 1 | 2018 | 8 | 0.580 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 31 | 0.570 |
Why?
|
| Quality of Life | 1 | 2022 | 557 | 0.570 |
Why?
|
| HIV Infections | 2 | 2020 | 421 | 0.570 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 53 | 0.560 |
Why?
|
| Disclosure | 1 | 2018 | 12 | 0.560 |
Why?
|
| Bias | 1 | 2018 | 23 | 0.560 |
Why?
|
| Conflict of Interest | 1 | 2018 | 8 | 0.560 |
Why?
|
| Mental Health | 5 | 2022 | 95 | 0.550 |
Why?
|
| Publishing | 1 | 2018 | 29 | 0.550 |
Why?
|
| Social Behavior | 1 | 2017 | 50 | 0.530 |
Why?
|
| Drug Discovery | 1 | 2017 | 12 | 0.530 |
Why?
|
| Informed Consent | 1 | 2017 | 21 | 0.530 |
Why?
|
| Treatment Outcome | 8 | 2022 | 2915 | 0.510 |
Why?
|
| Meaningful Use | 1 | 2016 | 3 | 0.510 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 135 | 0.500 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 189 | 0.490 |
Why?
|
| Adolescent Behavior | 3 | 2014 | 23 | 0.480 |
Why?
|
| Psychology, Adolescent | 3 | 2011 | 6 | 0.480 |
Why?
|
| Social Media | 2 | 2017 | 45 | 0.480 |
Why?
|
| Violence | 3 | 2024 | 34 | 0.470 |
Why?
|
| Students, Medical | 3 | 2004 | 48 | 0.470 |
Why?
|
| Social Support | 2 | 2016 | 174 | 0.460 |
Why?
|
| Antisocial Personality Disorder | 2 | 2011 | 8 | 0.440 |
Why?
|
| Physicians | 1 | 2015 | 103 | 0.420 |
Why?
|
| Military Personnel | 3 | 2019 | 37 | 0.420 |
Why?
|
| Education, Medical, Graduate | 3 | 2018 | 67 | 0.410 |
Why?
|
| Veterans Health | 1 | 2013 | 2 | 0.400 |
Why?
|
| Rape | 1 | 2013 | 5 | 0.400 |
Why?
|
| Child, Preschool | 6 | 2021 | 561 | 0.400 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 133 | 0.390 |
Why?
|
| Minority Groups | 2 | 2024 | 67 | 0.380 |
Why?
|
| Stress, Psychological | 2 | 2018 | 205 | 0.380 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2012 | 11 | 0.380 |
Why?
|
| Adolescent Development | 1 | 2012 | 6 | 0.380 |
Why?
|
| Chicago | 4 | 2019 | 788 | 0.380 |
Why?
|
| Group Processes | 1 | 2012 | 14 | 0.380 |
Why?
|
| Valproic Acid | 2 | 2009 | 13 | 0.380 |
Why?
|
| Ambulatory Care Facilities | 3 | 2021 | 33 | 0.370 |
Why?
|
| Systems Theory | 1 | 2011 | 2 | 0.370 |
Why?
|
| Family Therapy | 1 | 2011 | 2 | 0.370 |
Why?
|
| Retrospective Studies | 6 | 2022 | 2954 | 0.370 |
Why?
|
| Refugees | 4 | 2014 | 25 | 0.370 |
Why?
|
| Teaching | 3 | 2010 | 46 | 0.350 |
Why?
|
| Central Nervous System Stimulants | 2 | 2016 | 39 | 0.340 |
Why?
|
| Aged | 9 | 2021 | 7300 | 0.340 |
Why?
|
| Urban Population | 1 | 2011 | 124 | 0.340 |
Why?
|
| Ethnopsychology | 1 | 2010 | 1 | 0.340 |
Why?
|
| Cultural Competency | 1 | 2010 | 12 | 0.330 |
Why?
|
| Models, Educational | 1 | 2010 | 22 | 0.330 |
Why?
|
| Housing | 2 | 2021 | 15 | 0.330 |
Why?
|
| Surveys and Questionnaires | 10 | 2021 | 1019 | 0.330 |
Why?
|
| Cognition | 4 | 2021 | 915 | 0.320 |
Why?
|
| Morals | 2 | 2020 | 13 | 0.310 |
Why?
|
| Criminal Psychology | 1 | 2009 | 1 | 0.300 |
Why?
|
| Criminals | 1 | 2009 | 1 | 0.300 |
Why?
|
| Crime | 1 | 2009 | 6 | 0.300 |
Why?
|
| Patient Readmission | 2 | 2020 | 117 | 0.300 |
Why?
|
| Temperament | 1 | 2009 | 11 | 0.300 |
Why?
|
| Impulsive Behavior | 1 | 2009 | 14 | 0.300 |
Why?
|
| Sexual Behavior | 2 | 2021 | 46 | 0.300 |
Why?
|
| Anxiety Disorders | 2 | 2021 | 163 | 0.300 |
Why?
|
| Curriculum | 3 | 2004 | 127 | 0.290 |
Why?
|
| Infant, Newborn | 2 | 2021 | 526 | 0.290 |
Why?
|
| Mass Screening | 2 | 2020 | 152 | 0.290 |
Why?
|
| Character | 1 | 2008 | 3 | 0.290 |
Why?
|
| Sex Offenses | 2 | 2018 | 23 | 0.280 |
Why?
|
| Mobile Applications | 2 | 2019 | 27 | 0.280 |
Why?
|
| Arousal | 1 | 2008 | 47 | 0.280 |
Why?
|
| Hospitalization | 2 | 2020 | 281 | 0.270 |
Why?
|
| Delirium | 1 | 2007 | 12 | 0.270 |
Why?
|
| Prevalence | 7 | 2014 | 372 | 0.260 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2006 | 2 | 0.260 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2006 | 5 | 0.260 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 15 | 0.260 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2006 | 21 | 0.260 |
Why?
|
| Comorbidity | 4 | 2020 | 423 | 0.260 |
Why?
|
| Self Disclosure | 1 | 2006 | 6 | 0.260 |
Why?
|
| Psychopathology | 1 | 2006 | 6 | 0.260 |
Why?
|
| Social Problems | 2 | 2023 | 6 | 0.250 |
Why?
|
| Simvastatin | 1 | 2005 | 12 | 0.240 |
Why?
|
| Transaminases | 1 | 2005 | 6 | 0.240 |
Why?
|
| Rhabdomyolysis | 1 | 2005 | 5 | 0.240 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 752 | 0.240 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2005 | 28 | 0.240 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 22 | 0.240 |
Why?
|
| Triazoles | 1 | 2005 | 29 | 0.240 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 88 | 0.230 |
Why?
|
| Algorithms | 1 | 2007 | 290 | 0.230 |
Why?
|
| Prejudice | 2 | 2003 | 30 | 0.230 |
Why?
|
| Sex Factors | 5 | 2020 | 380 | 0.220 |
Why?
|
| California | 3 | 2010 | 35 | 0.220 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2004 | 34 | 0.220 |
Why?
|
| Education, Medical | 1 | 2004 | 41 | 0.220 |
Why?
|
| Pediatrics | 2 | 2020 | 38 | 0.220 |
Why?
|
| Students | 1 | 2024 | 37 | 0.210 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2020 | 18 | 0.200 |
Why?
|
| Mentors | 1 | 2023 | 34 | 0.200 |
Why?
|
| Self Efficacy | 1 | 2023 | 50 | 0.200 |
Why?
|
| Dementia | 1 | 2006 | 382 | 0.190 |
Why?
|
| Learning | 1 | 2023 | 59 | 0.190 |
Why?
|
| Tertiary Care Centers | 2 | 2019 | 63 | 0.190 |
Why?
|
| Mental Processes | 1 | 2022 | 13 | 0.190 |
Why?
|
| Yoga | 2 | 2020 | 10 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 22 | 0.190 |
Why?
|
| Education, Continuing | 1 | 2022 | 9 | 0.180 |
Why?
|
| Psychotherapy, Group | 2 | 2019 | 37 | 0.180 |
Why?
|
| Prognosis | 2 | 2019 | 719 | 0.180 |
Why?
|
| Internship and Residency | 2 | 2018 | 198 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2022 | 126 | 0.180 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 66 | 0.180 |
Why?
|
| Mindfulness | 2 | 2020 | 46 | 0.180 |
Why?
|
| Endpoint Determination | 1 | 2021 | 21 | 0.170 |
Why?
|
| Data Collection | 1 | 2021 | 79 | 0.170 |
Why?
|
| Patients | 1 | 2021 | 31 | 0.170 |
Why?
|
| Ethanol | 1 | 2021 | 81 | 0.170 |
Why?
|
| Communication | 1 | 2001 | 96 | 0.170 |
Why?
|
| Psychotherapy | 1 | 2021 | 38 | 0.170 |
Why?
|
| Anxiety | 1 | 2021 | 143 | 0.170 |
Why?
|
| Forecasting | 1 | 2020 | 77 | 0.170 |
Why?
|
| Psychotherapy, Brief | 1 | 2020 | 2 | 0.160 |
Why?
|
| Hospitals | 1 | 2021 | 155 | 0.160 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 24 | 0.160 |
Why?
|
| Social Adjustment | 2 | 2017 | 20 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 269 | 0.160 |
Why?
|
| Supervised Machine Learning | 1 | 2019 | 10 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2019 | 9 | 0.160 |
Why?
|
| Brain | 1 | 2006 | 1123 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2019 | 24 | 0.150 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 14 | 0.150 |
Why?
|
| Global Health | 1 | 2019 | 29 | 0.150 |
Why?
|
| Trauma Centers | 1 | 2019 | 8 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2019 | 73 | 0.150 |
Why?
|
| HIV | 1 | 2019 | 39 | 0.150 |
Why?
|
| Physician-Patient Relations | 2 | 2013 | 36 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 34 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 11 | 0.150 |
Why?
|
| Hydrocortisone | 1 | 2018 | 33 | 0.150 |
Why?
|
| Personality Inventory | 2 | 2009 | 68 | 0.150 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 103 | 0.140 |
Why?
|
| Conduct Disorder | 2 | 2009 | 2 | 0.140 |
Why?
|
| Occupational Diseases | 1 | 2018 | 21 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 35 | 0.140 |
Why?
|
| Infant | 1 | 2019 | 478 | 0.140 |
Why?
|
| Psychiatric Nursing | 1 | 2018 | 44 | 0.140 |
Why?
|
| Survivors | 1 | 2018 | 69 | 0.140 |
Why?
|
| Risk Factors | 5 | 2021 | 1955 | 0.140 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 22 | 0.130 |
Why?
|
| Minors | 2 | 2014 | 5 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 158 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2017 | 17 | 0.130 |
Why?
|
| Parents | 1 | 2018 | 107 | 0.130 |
Why?
|
| Catheterization, Central Venous | 1 | 2017 | 34 | 0.130 |
Why?
|
| Resilience, Psychological | 2 | 2014 | 20 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2017 | 58 | 0.120 |
Why?
|
| Thrombosis | 1 | 2017 | 52 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2015 | 105 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2020 | 537 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 3657 | 0.110 |
Why?
|
| Escape Reaction | 1 | 2014 | 1 | 0.110 |
Why?
|
| Feeding and Eating Disorders | 1 | 2014 | 10 | 0.110 |
Why?
|
| Interpersonal Relations | 2 | 2012 | 86 | 0.110 |
Why?
|
| Age Factors | 2 | 2020 | 623 | 0.110 |
Why?
|
| Personality Disorders | 1 | 2013 | 12 | 0.100 |
Why?
|
| United Kingdom | 2 | 2004 | 27 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2006 | 847 | 0.100 |
Why?
|
| Psychology, Military | 1 | 2013 | 1 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 3 | 0.100 |
Why?
|
| Repression, Psychology | 1 | 2013 | 3 | 0.100 |
Why?
|
| Physician's Role | 1 | 2013 | 14 | 0.100 |
Why?
|
| Mental Status Schedule | 1 | 2013 | 65 | 0.100 |
Why?
|
| Medical History Taking | 1 | 2013 | 24 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 800 | 0.100 |
Why?
|
| Acrosome | 1 | 1992 | 1 | 0.100 |
Why?
|
| Spermatocytes | 1 | 1992 | 1 | 0.100 |
Why?
|
| Personality | 1 | 2013 | 41 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 1992 | 9 | 0.100 |
Why?
|
| Physical Examination | 1 | 2013 | 85 | 0.100 |
Why?
|
| Mass Behavior | 1 | 2012 | 1 | 0.100 |
Why?
|
| Social Change | 1 | 2012 | 3 | 0.100 |
Why?
|
| Animals | 2 | 2017 | 3238 | 0.090 |
Why?
|
| Psychology | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 36 | 0.090 |
Why?
|
| Competency-Based Education | 1 | 2010 | 10 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2019 | 1386 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2009 | 45 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 161 | 0.080 |
Why?
|
| Interview, Psychological | 1 | 2009 | 39 | 0.080 |
Why?
|
| Child, Abandoned | 1 | 2009 | 2 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2019 | 208 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 242 | 0.070 |
Why?
|
| Free Association | 1 | 2008 | 1 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2019 | 90 | 0.070 |
Why?
|
| Austria | 3 | 2014 | 3 | 0.070 |
Why?
|
| Heart Rate | 1 | 2008 | 104 | 0.070 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2007 | 1 | 0.070 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2007 | 4 | 0.070 |
Why?
|
| Risperidone | 1 | 2007 | 4 | 0.070 |
Why?
|
| Haloperidol | 1 | 2007 | 3 | 0.070 |
Why?
|
| Hyperkinesis | 1 | 2007 | 8 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 13 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2007 | 23 | 0.070 |
Why?
|
| Electroshock | 1 | 2006 | 1 | 0.070 |
Why?
|
| Inclusion Bodies | 1 | 2006 | 10 | 0.070 |
Why?
|
| Tauopathies | 1 | 2006 | 12 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 50 | 0.060 |
Why?
|
| Atrophy | 1 | 2006 | 61 | 0.060 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 1 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 26 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 314 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 350 | 0.060 |
Why?
|
| Psychopharmacology | 1 | 2006 | 2 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 75 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 35 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 302 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 17 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2019 | 164 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 240 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 282 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 88 | 0.060 |
Why?
|
| Piperazines | 1 | 2005 | 81 | 0.060 |
Why?
|
| Disease Progression | 1 | 2006 | 517 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 173 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 355 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 122 | 0.060 |
Why?
|
| Illinois | 1 | 2004 | 216 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2017 | 265 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2003 | 55 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 574 | 0.050 |
Why?
|
| Life Change Events | 2 | 2014 | 33 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 789 | 0.050 |
Why?
|
| Africa | 2 | 2014 | 9 | 0.050 |
Why?
|
| Warfare | 2 | 2014 | 12 | 0.050 |
Why?
|
| Parenting | 2 | 2018 | 66 | 0.050 |
Why?
|
| State Medicine | 1 | 2001 | 3 | 0.050 |
Why?
|
| Unified Medical Language System | 1 | 2020 | 1 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2020 | 6 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 7 | 0.040 |
Why?
|
| Medical Records | 1 | 2020 | 28 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 7 | 0.040 |
Why?
|
| Text Messaging | 1 | 2019 | 13 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 120 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 244 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 90 | 0.040 |
Why?
|
| Psychological Techniques | 1 | 2018 | 1 | 0.040 |
Why?
|
| Population | 1 | 2018 | 4 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 120 | 0.040 |
Why?
|
| Psychometrics | 1 | 2019 | 175 | 0.040 |
Why?
|
| Health Promotion | 1 | 2019 | 122 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 477 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 431 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 369 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 36 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2017 | 6 | 0.030 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 578 | 0.030 |
Why?
|
| Checklist | 1 | 2017 | 33 | 0.030 |
Why?
|
| Central Venous Catheters | 1 | 2017 | 2 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 79 | 0.030 |
Why?
|
| India | 1 | 2017 | 16 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 159 | 0.030 |
Why?
|
| Research | 1 | 2016 | 34 | 0.030 |
Why?
|
| Methylphenidate | 1 | 2016 | 8 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 249 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 40 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 92 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 70 | 0.030 |
Why?
|
| Family Relations | 1 | 2014 | 12 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 64 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1992 | 2 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1992 | 3 | 0.020 |
Why?
|
| Spermatids | 1 | 1992 | 2 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 6 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1992 | 8 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 28 | 0.020 |
Why?
|
| Antibodies | 1 | 1992 | 43 | 0.020 |
Why?
|
| Self Report | 1 | 2013 | 192 | 0.020 |
Why?
|
| Yugoslavia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Turkey | 1 | 2011 | 6 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2011 | 18 | 0.020 |
Why?
|
| Motivation | 1 | 2011 | 80 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1403 | 0.020 |
Why?
|
| Child Welfare | 1 | 2009 | 15 | 0.020 |
Why?
|
| Mice | 1 | 1992 | 1224 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2006 | 9 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2005 | 3 | 0.010 |
Why?
|
| Expert Testimony | 1 | 2005 | 10 | 0.010 |
Why?
|
| Autistic Disorder | 1 | 2005 | 37 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2005 | 99 | 0.010 |
Why?
|